The Internal Revenue Service has extended some Affordable Care Act reporting deadlines to help companies meet the requirements.

The year 2015 was undoubtedly one of seismic change for the health insurance industry, with no shortage of game-changing headlines and issues.

Medicare officials say researchers and the public will now have an easier way to analyze spending on costly prescription drugs.

Americans want to know what the next U.S. president will do to lower their rising healthcare costs, a priority shared by Republican and Democratic voters and second only to keeping the country safe, according to a recent Reuters/Ipsos poll.

Prices rose faster than inflation for 22% of top generic drugs reviewed between 2005 and 2014, according to a report released Thursday by HHS' Office of Inspector General.

A newly qualified November 2016 ballot measure would impose price controls on state drug purchases, potentially setting up an expensive battle with the pharmaceutical industry.